fanta.bio Sample: CNhs11969
18578 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| HIF1A SRX11007095 | HK-2 Kidney | 2676 / 21175 (12.6%) | 1000 / 211750 (0.5%) | −324.0 | −324.0 | 26.76 |
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 1287 / 21175 (6.1%) | 485 / 211750 (0.2%) | −324.0 | −324.0 | 26.54 |
| HIF1A SRX20663235 | HK-2 Kidney | 612 / 21175 (2.9%) | 275 / 211750 (0.1%) | −324.0 | −324.0 | 22.25 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 1901 / 21175 (9.0%) | 862 / 211750 (0.4%) | −324.0 | −324.0 | 22.05 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 1836 / 21175 (8.7%) | 919 / 211750 (0.4%) | −324.0 | −324.0 | 19.98 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 2676 / 21175 (12.6%) | 1347 / 211750 (0.6%) | −324.0 | −324.0 | 19.87 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 2591 / 21175 (12.2%) | 1333 / 211750 (0.6%) | −324.0 | −324.0 | 19.44 |
| BRD4 SRX9419935 | BT-474 Breast | 4664 / 21175 (22.0%) | 2930 / 211750 (1.4%) | −324.0 | −324.0 | 15.92 |
| SCML2 SRX644728 | 293 Kidney | 1488 / 21175 (7.0%) | 943 / 211750 (0.4%) | −324.0 | −324.0 | 15.78 |
| MED1 SRX9419945 | BT-474 Breast | 4588 / 21175 (21.7%) | 2981 / 211750 (1.4%) | −324.0 | −324.0 | 15.39 |
| BRD4 SRX9419937 | BT-474 Breast | 4571 / 21175 (21.6%) | 3006 / 211750 (1.4%) | −324.0 | −324.0 | 15.21 |
| MED1 SRX9419944 | BT-474 Breast | 4476 / 21175 (21.1%) | 2951 / 211750 (1.4%) | −324.0 | −324.0 | 15.17 |
| BRD4 SRX9419938 | BT-474 Breast | 4692 / 21175 (22.2%) | 3117 / 211750 (1.5%) | −324.0 | −324.0 | 15.05 |
| FOXP1 SRX736067 | LNCAP Prostate | 2064 / 21175 (9.7%) | 1373 / 211750 (0.6%) | −324.0 | −324.0 | 15.03 |
| BRD4 SRX9419936 | BT-474 Breast | 4692 / 21175 (22.2%) | 3127 / 211750 (1.5%) | −324.0 | −324.0 | 15.00 |
| MED1 SRX9419946 | BT-474 Breast | 4695 / 21175 (22.2%) | 3139 / 211750 (1.5%) | −324.0 | −324.0 | 14.96 |
| MED1 SRX9419947 | BT-474 Breast | 4526 / 21175 (21.4%) | 3116 / 211750 (1.5%) | −324.0 | −324.0 | 14.53 |
| MYH11 SRX265221 | ME-1 Blood | 945 / 21175 (4.5%) | 709 / 211750 (0.3%) | −324.0 | −324.0 | 13.33 |
| EZH2 SRX2146136 | LNCAP Prostate | 10021 / 21175 (47.3%) | 9193 / 211750 (4.3%) | −324.0 | −324.0 | 10.90 |
| BRD4 SRX736201 | 90-8TL Neural | 7160 / 21175 (33.8%) | 7770 / 211750 (3.7%) | −324.0 | −324.0 | 9.21 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 933 / 21175 (4.4%) | 1069 / 211750 (0.5%) | −324.0 | −324.0 | 8.73 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 2103 / 21175 (9.9%) | 3211 / 211750 (1.5%) | −324.0 | −324.0 | 6.55 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 1838 / 21175 (8.7%) | 4420 / 211750 (2.1%) | −324.0 | −324.0 | 4.16 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 2291 / 21175 (10.8%) | 6043 / 211750 (2.9%) | −324.0 | −324.0 | 3.79 |
| AGO2 SRX6783958 | Hep G2 Liver | 1746 / 21175 (8.2%) | 5294 / 211750 (2.5%) | −324.0 | −324.0 | 3.30 |
| AGO2 SRX6783957 | Hep G2 Liver | 1759 / 21175 (8.3%) | 5409 / 211750 (2.6%) | −324.0 | −324.0 | 3.25 |
| AGO2 SRX4708039 | Hep G2 Liver | 2775 / 21175 (13.1%) | 8922 / 211750 (4.2%) | −324.0 | −324.0 | 3.11 |
| Epitope tags SRX10549776 | K-562 Blood | 1930 / 21175 (9.1%) | 6353 / 211750 (3.0%) | −324.0 | −324.0 | 3.04 |
| KAT7 SRX101303 | RKO Digestive tract | 1869 / 21175 (8.8%) | 6180 / 211750 (2.9%) | −324.0 | −324.0 | 3.02 |
| EED SRX8175103 | ES cells Pluripotent stem cell | 2919 / 21175 (13.8%) | 11779 / 211750 (5.6%) | −324.0 | −324.0 | 2.48 |
| 5-mC SRX882965 | LNCAP Prostate | 3170 / 21175 (15.0%) | 14331 / 211750 (6.8%) | −324.0 | −324.0 | 2.21 |
| 5-mC SRX882970 | LNCAP Prostate | 3947 / 21175 (18.6%) | 18591 / 211750 (8.8%) | −324.0 | −324.0 | 2.12 |
| 5-mC SRX882968 | LNCAP Prostate | 3866 / 21175 (18.3%) | 18461 / 211750 (8.7%) | −324.0 | −324.0 | 2.09 |
| RUNX1 SRX2513054 | 293 Kidney | 4472 / 21175 (21.1%) | 21739 / 211750 (10.3%) | −324.0 | −324.0 | 2.06 |
| CIC SRX13262055 | Astrocytes Neural | 4083 / 21175 (19.3%) | 20455 / 211750 (9.7%) | −324.0 | −324.0 | 2.00 |
| FOXA1 SRX4815198 | MCF-7 Breast | 1210 / 21175 (5.7%) | 30481 / 211750 (14.4%) | −324.0 | −324.0 | 0.40 |
| PBX4 SRX2731658 | PC-3 Prostate | 1024 / 21175 (4.8%) | 33557 / 211750 (15.8%) | −324.0 | −324.0 | 0.31 |
| FOS SRX150478 | MCF 10A Breast | 723 / 21175 (3.4%) | 25623 / 211750 (12.1%) | −324.0 | −324.0 | 0.28 |
| YAP1 SRX757325 | H2052 Lung | 729 / 21175 (3.4%) | 25963 / 211750 (12.3%) | −324.0 | −324.0 | 0.28 |
| FOS SRX150477 | MCF 10A Breast | 699 / 21175 (3.3%) | 25004 / 211750 (11.8%) | −324.0 | −324.0 | 0.28 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 653 / 21175 (3.1%) | 23655 / 211750 (11.2%) | −324.0 | −324.0 | 0.28 |
| YAP1 SRX757326 | H2052 Lung | 593 / 21175 (2.8%) | 23234 / 211750 (11.0%) | −324.0 | −324.0 | 0.26 |
| FOS SRX4192880 | MCF 10A Breast | 511 / 21175 (2.4%) | 20329 / 211750 (9.6%) | −324.0 | −324.0 | 0.25 |
| BRD1 SRX286203 | RKO Digestive tract | 1646 / 21175 (7.8%) | 4962 / 211750 (2.3%) | −323.3 | −320.4 | 3.32 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 794 / 21175 (3.7%) | 1087 / 211750 (0.5%) | −321.7 | −318.8 | 7.30 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 1236 / 21175 (5.8%) | 30602 / 211750 (14.5%) | −320.2 | −317.3 | 0.40 |
| TP53 SRX19538279 | Osteoblasts Bone | 538 / 21175 (2.5%) | 353 / 211750 (0.2%) | −319.0 | −316.1 | 15.24 |
| HMGB1 SRX10567335 | HUVEC Cardiovascular | 1907 / 21175 (9.0%) | 6523 / 211750 (3.1%) | −315.7 | −312.9 | 2.92 |
| FOXA1 SRX4815197 | MCF-7 Breast | 874 / 21175 (4.1%) | 24981 / 211750 (11.8%) | −313.9 | −311.1 | 0.35 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 789 / 21175 (3.7%) | 1110 / 211750 (0.5%) | −313.8 | −311.0 | 7.11 |
| FOXA1 SRX176862 | MCF-7 Breast | 424 / 21175 (2.0%) | 17495 / 211750 (8.3%) | −313.1 | −310.3 | 0.24 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 676 / 21175 (3.2%) | 745 / 211750 (0.4%) | −312.8 | −310.0 | 9.07 |
| FOS SRX150476 | MCF 10A Breast | 594 / 21175 (2.8%) | 20318 / 211750 (9.6%) | −308.8 | −306.0 | 0.29 |
| FOS SRX150517 | MCF 10A Breast | 599 / 21175 (2.8%) | 20215 / 211750 (9.5%) | −302.9 | −300.1 | 0.30 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 687 / 21175 (3.2%) | 823 / 211750 (0.4%) | −302.7 | −299.9 | 8.35 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 409 / 21175 (1.9%) | 16809 / 211750 (7.9%) | −299.1 | −296.3 | 0.24 |
| JUN SRX17561461 | LPS141 Adipocyte | 485 / 21175 (2.3%) | 18115 / 211750 (8.6%) | −297.8 | −295.0 | 0.27 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 1277 / 21175 (6.0%) | 30301 / 211750 (14.3%) | −295.5 | −292.8 | 0.42 |
| EED SRX8175102 | ES cells Pluripotent stem cell | 2336 / 21175 (11.0%) | 9502 / 211750 (4.5%) | −293.4 | −290.7 | 2.46 |
| BRPF3 SRX796084 | RKO Digestive tract | 2006 / 21175 (9.5%) | 7449 / 211750 (3.5%) | −292.7 | −290.0 | 2.69 |
| BRPF3 SRX796086 | RKO Digestive tract | 1943 / 21175 (9.2%) | 7083 / 211750 (3.3%) | −291.6 | −288.9 | 2.74 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 440 / 21175 (2.1%) | 17107 / 211750 (8.1%) | −290.6 | −287.8 | 0.26 |
| FOXA1 SRX176863 | MCF-7 Breast | 421 / 21175 (2.0%) | 16731 / 211750 (7.9%) | −289.5 | −286.7 | 0.25 |
| JUNB SRX8488088 | SUM 229PE Breast | 709 / 21175 (3.3%) | 21575 / 211750 (10.2%) | −289.3 | −286.6 | 0.33 |
| FOXA1 SRX3931044 | MCF-7 Breast | 813 / 21175 (3.8%) | 23134 / 211750 (10.9%) | −287.1 | −284.4 | 0.35 |
| BRPF3 SRX796085 | RKO Digestive tract | 1460 / 21175 (6.9%) | 4388 / 211750 (2.1%) | −286.7 | −284.0 | 3.33 |
| MEAF6 DRX234811 | 293 Kidney | 2243 / 21175 (10.6%) | 9083 / 211750 (4.3%) | −283.3 | −280.6 | 2.47 |
| TP53 SRX19538274 | U2OS Bone | 432 / 21175 (2.0%) | 224 / 211750 (0.1%) | −279.3 | −276.6 | 19.29 |
| MEAF6 DRX300417 | 293 Kidney | 2068 / 21175 (9.8%) | 8067 / 211750 (3.8%) | −278.0 | −275.3 | 2.56 |
| TP53 SRX19538268 | U2OS Bone | 427 / 21175 (2.0%) | 220 / 211750 (0.1%) | −276.6 | −274.0 | 19.41 |
| FOXA1 SRX1161177 | MCF-7 Breast | 353 / 21175 (1.7%) | 15106 / 211750 (7.1%) | −276.4 | −273.7 | 0.23 |
| GATA3 SRX190239 | MCF-7 Breast | 542 / 21175 (2.6%) | 18422 / 211750 (8.7%) | −276.4 | −273.7 | 0.29 |
| JUN SRX11051045 | hTERT RPE-1 Neural | 1269 / 21175 (6.0%) | 29443 / 211750 (13.9%) | −275.4 | −272.7 | 0.43 |
| TP53 SRX19538276 | U2OS Bone | 430 / 21175 (2.0%) | 230 / 211750 (0.1%) | −275.0 | −272.4 | 18.70 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 248 / 21175 (1.2%) | 13035 / 211750 (6.2%) | −274.4 | −271.7 | 0.19 |
| FOSL2 SRX10640866 | SK-MEL-147 Epidermis | 737 / 21175 (3.5%) | 21497 / 211750 (10.2%) | −273.8 | −271.1 | 0.34 |
| SMARCC1 SRX11379507 | Liposarcoma, Myxoid Adipocyte | 816 / 21175 (3.9%) | 22724 / 211750 (10.7%) | −273.7 | −271.1 | 0.36 |
| ERG SRX026653 | CD34 Hematopoietic stem cells Blood | 2168 / 21175 (10.2%) | 8781 / 211750 (4.1%) | −273.2 | −270.6 | 2.47 |
| RELA SRX2207673 | HUVEC Cardiovascular | 1459 / 21175 (6.9%) | 31958 / 211750 (15.1%) | −272.0 | −269.4 | 0.46 |
| BMI1 SRX7196715 | SU-DIPG-IV Neural | 2396 / 21175 (11.3%) | 10314 / 211750 (4.9%) | −270.5 | −267.9 | 2.32 |
| TRP47 SRX4548329 | THP-1 Blood | 3365 / 21175 (15.9%) | 17090 / 211750 (8.1%) | −270.5 | −267.9 | 1.97 |
| SMARCA2 SRX8119674 | MRC-5 Lung | 942 / 21175 (4.4%) | 24503 / 211750 (11.6%) | −270.0 | −267.4 | 0.38 |
| FOSL2 SRX10640865 | SK-MEL-147 Epidermis | 747 / 21175 (3.5%) | 21418 / 211750 (10.1%) | −266.7 | −264.1 | 0.35 |
| GATA3 SRX190194 | SK-N-SH Neural | 943 / 21175 (4.5%) | 24371 / 211750 (11.5%) | −265.9 | −263.3 | 0.39 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 375 / 21175 (1.8%) | 15190 / 211750 (7.2%) | −265.8 | −263.2 | 0.25 |
| FOXA1 SRX371482 | MCF-7 Breast | 561 / 21175 (2.6%) | 18352 / 211750 (8.7%) | −264.4 | −261.8 | 0.31 |
| SREBF2 SRX5359048 | HCC70 Breast | 2219 / 21175 (10.5%) | 9278 / 211750 (4.4%) | −263.8 | −261.2 | 2.39 |
| JUNB SRX10119396 | MDA-MB-231 Breast | 357 / 21175 (1.7%) | 14790 / 211750 (7.0%) | −263.3 | −260.7 | 0.24 |
| SMARCA4 SRX5212366 | Mel270 Others | 498 / 21175 (2.4%) | 17203 / 211750 (8.1%) | −261.4 | −258.8 | 0.29 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 429 / 21175 (2.0%) | 264 / 211750 (0.1%) | −260.7 | −258.1 | 16.25 |
| FOXA1 SRX1161173 | MCF-7 Breast | 277 / 21175 (1.3%) | 13184 / 211750 (6.2%) | −259.8 | −257.3 | 0.21 |
| FOS SRX4192879 | MCF 10A Breast | 427 / 21175 (2.0%) | 15923 / 211750 (7.5%) | −259.6 | −257.0 | 0.27 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 323 / 21175 (1.5%) | 14035 / 211750 (6.6%) | −259.1 | −256.6 | 0.23 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 318 / 21175 (1.5%) | 13920 / 211750 (6.6%) | −258.3 | −255.7 | 0.23 |
| Epitope tags DRX443510 | 293 Kidney | 1918 / 21175 (9.1%) | 7457 / 211750 (3.5%) | −258.2 | −255.6 | 2.57 |
| SMARCA4 SRX5212362 | Mel270 Others | 679 / 21175 (3.2%) | 20027 / 211750 (9.5%) | −257.2 | −254.7 | 0.34 |
| TLE3 SRX4815191 | MCF-7 Breast | 362 / 21175 (1.7%) | 14671 / 211750 (6.9%) | −256.4 | −253.9 | 0.25 |
| SMARCA4 SRX5212357 | Mel270 Others | 556 / 21175 (2.6%) | 17992 / 211750 (8.5%) | −255.8 | −253.2 | 0.31 |
| CNOT3 SRX886405 | HCT 116 Digestive tract | 2464 / 21175 (11.6%) | 11064 / 211750 (5.2%) | −255.7 | −253.1 | 2.23 |
| ESR1 SRX371478 | MCF-7 Breast | 509 / 21175 (2.4%) | 17202 / 211750 (8.1%) | −255.5 | −253.0 | 0.30 |
| FOXA1 SRX371483 | MCF-7 Breast | 441 / 21175 (2.1%) | 16020 / 211750 (7.6%) | −254.8 | −252.3 | 0.28 |
| JUNB SRX8488073 | SUM 229PE Breast | 746 / 21175 (3.5%) | 20994 / 211750 (9.9%) | −254.8 | −252.2 | 0.36 |
| FOSL2 SRX3367141 | SK-MEL-147 Epidermis | 539 / 21175 (2.5%) | 17641 / 211750 (8.3%) | −253.6 | −251.1 | 0.31 |
| BMI1 SRX7196721 | SF8628 Neural | 2231 / 21175 (10.5%) | 9548 / 211750 (4.5%) | −253.5 | −251.0 | 2.34 |
| MITF SRX1555436 | 501A Epidermis | 2534 / 21175 (12.0%) | 11587 / 211750 (5.5%) | −253.5 | −251.0 | 2.19 |
| FOXA1 SRX1161176 | MCF-7 Breast | 359 / 21175 (1.7%) | 14518 / 211750 (6.9%) | −253.1 | −250.6 | 0.25 |
| ESR1 SRX7624157 | MCF-7 Breast | 1070 / 21175 (5.1%) | 25758 / 211750 (12.2%) | −252.9 | −250.4 | 0.42 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 318 / 21175 (1.5%) | 13759 / 211750 (6.5%) | −252.9 | −250.4 | 0.23 |
| JUN SRX11051046 | hTERT RPE-1 Neural | 1184 / 21175 (5.6%) | 27386 / 211750 (12.9%) | −252.7 | −250.2 | 0.43 |
| TP53 SRX396254 | Fibroblasts Others | 1175 / 21175 (5.5%) | 3271 / 211750 (1.5%) | −252.6 | −250.1 | 3.59 |
| ING5 SRX286202 | RKO Digestive tract | 1709 / 21175 (8.1%) | 6275 / 211750 (3.0%) | −252.1 | −249.6 | 2.72 |
| RELA SRX2207672 | HUVEC Cardiovascular | 1627 / 21175 (7.7%) | 33441 / 211750 (15.8%) | −252.0 | −249.5 | 0.49 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 465 / 21175 (2.2%) | 16344 / 211750 (7.7%) | −252.0 | −249.5 | 0.28 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 694 / 21175 (3.3%) | 20055 / 211750 (9.5%) | −251.1 | −248.6 | 0.35 |
| SMARCA2 SRX8119677 | MeT-5A Others | 653 / 21175 (3.1%) | 19376 / 211750 (9.2%) | −250.2 | −247.8 | 0.34 |
| SMARCA4 SRX5212371 | Mel270 Others | 549 / 21175 (2.6%) | 17679 / 211750 (8.3%) | −249.7 | −247.2 | 0.31 |
| TP53 SRX19538267 | U2OS Bone | 386 / 21175 (1.8%) | 200 / 211750 (0.1%) | −249.6 | −247.1 | 19.30 |
| TP53 SRX19538275 | U2OS Bone | 392 / 21175 (1.9%) | 213 / 211750 (0.1%) | −249.3 | −246.9 | 18.40 |
| FOXA1 SRX371481 | MCF-7 Breast | 417 / 21175 (2.0%) | 15430 / 211750 (7.3%) | −249.3 | −246.8 | 0.27 |
| FOSL2 SRX10640867 | SK-MEL-147 Epidermis | 695 / 21175 (3.3%) | 19959 / 211750 (9.4%) | −247.9 | −245.4 | 0.35 |
| JUNB SRX10119386 | MCF 10A Breast | 331 / 21175 (1.6%) | 13844 / 211750 (6.5%) | −247.8 | −245.3 | 0.24 |
| TRIM25 SRX1660873 | Breast cancer cells Breast | 2475 / 21175 (11.7%) | 11336 / 211750 (5.4%) | −246.3 | −243.9 | 2.18 |
| FOXA1 SRX1161175 | MCF-7 Breast | 272 / 21175 (1.3%) | 12686 / 211750 (6.0%) | −245.9 | −243.5 | 0.21 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 351 / 21175 (1.7%) | 14145 / 211750 (6.7%) | −245.5 | −243.1 | 0.25 |
| TCF12 SRX190356 | SK-N-SH Neural | 1151 / 21175 (5.4%) | 26622 / 211750 (12.6%) | −245.0 | −242.6 | 0.43 |
| JUN SRX883584 | MDA-MB-231 Breast | 633 / 21175 (3.0%) | 18812 / 211750 (8.9%) | −242.9 | −240.4 | 0.34 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 476 / 21175 (2.2%) | 16239 / 211750 (7.7%) | −242.8 | −240.4 | 0.29 |
| JUNB SRX10119395 | MDA-MB-231 Breast | 343 / 21175 (1.6%) | 13914 / 211750 (6.6%) | −242.7 | −240.3 | 0.25 |
| JUN SRX4192884 | MCF 10A Breast | 306 / 21175 (1.4%) | 13218 / 211750 (6.2%) | −242.3 | −239.8 | 0.23 |
| MEAF6 SRX10606585 | GIST-T1 Digestive tract | 2223 / 21175 (10.5%) | 9728 / 211750 (4.6%) | −241.6 | −239.2 | 2.29 |
| ESR1 SRX371469 | MCF-7 Breast | 424 / 21175 (2.0%) | 15304 / 211750 (7.2%) | −241.4 | −239.0 | 0.28 |
| TP53 SRX19538273 | U2OS Bone | 378 / 21175 (1.8%) | 204 / 211750 (0.1%) | −241.0 | −238.6 | 18.53 |
| MEAF6 SRX10606584 | GIST-T1 Digestive tract | 2026 / 21175 (9.6%) | 8451 / 211750 (4.0%) | −240.7 | −238.3 | 2.40 |
| JUNB SRX4192882 | MCF 10A Breast | 286 / 21175 (1.4%) | 12794 / 211750 (6.0%) | −240.6 | −238.2 | 0.22 |
| IRF3 SRX11453858 | Hep G2 Liver | 318 / 21175 (1.5%) | 95 / 211750 (0.0%) | −240.6 | −238.2 | 33.47 |
| FOXA1 SRX1389381 | CFPAC-1 Pancreas | 332 / 21175 (1.6%) | 13570 / 211750 (6.4%) | −238.1 | −235.7 | 0.24 |
| MECOM SRX23677885 | HNT-34 Blood | 2247 / 21175 (10.6%) | 9964 / 211750 (4.7%) | −237.9 | −235.6 | 2.26 |
| ESR1 SRX7624156 | MCF-7 Breast | 674 / 21175 (3.2%) | 19283 / 211750 (9.1%) | −237.7 | −235.3 | 0.35 |
| MECOM SRX23677896 | HNT-34 Blood | 2699 / 21175 (12.7%) | 13090 / 211750 (6.2%) | −237.7 | −235.3 | 2.06 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 384 / 21175 (1.8%) | 14480 / 211750 (6.8%) | −237.4 | −235.0 | 0.27 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 596 / 21175 (2.8%) | 18017 / 211750 (8.5%) | −236.9 | −234.5 | 0.33 |
| FOSL2 SRX190296 | SK-N-SH Neural | 542 / 21175 (2.6%) | 17137 / 211750 (8.1%) | −236.6 | −234.3 | 0.32 |
| SMARCA4 SRX5075176 | Neural progenitor cells Neural | 997 / 21175 (4.7%) | 24071 / 211750 (11.4%) | −235.8 | −233.5 | 0.41 |
| CDYL2 SRX8321653 | MCF-7 Breast | 2323 / 21175 (11.0%) | 10545 / 211750 (5.0%) | −234.6 | −232.2 | 2.20 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 800 / 21175 (3.8%) | 1653 / 211750 (0.8%) | −234.4 | −232.0 | 4.84 |
| TP53 SRX19538280 | Osteoblasts Bone | 403 / 21175 (1.9%) | 277 / 211750 (0.1%) | −234.3 | −232.0 | 14.55 |
| ESR1 SRX20282961 | MCF-7 Breast | 541 / 21175 (2.6%) | 17033 / 211750 (8.0%) | −234.1 | −231.8 | 0.32 |
| JADE3 DRX300415 | 293 Kidney | 1949 / 21175 (9.2%) | 8082 / 211750 (3.8%) | −233.6 | −231.3 | 2.41 |
| MECOM SRX23677884 | HNT-34 Blood | 2207 / 21175 (10.4%) | 9801 / 211750 (4.6%) | −232.7 | −230.3 | 2.25 |
| SS18 SRX3468047 | Fibroblasts Others | 1092 / 21175 (5.2%) | 25308 / 211750 (12.0%) | −232.6 | −230.2 | 0.43 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 623 / 21175 (2.9%) | 18283 / 211750 (8.6%) | −232.0 | −229.7 | 0.34 |
| PRRX1 SRX15235713 | Hs 578T Breast | 495 / 21175 (2.3%) | 16196 / 211750 (7.6%) | −231.7 | −229.3 | 0.31 |
| GATA3 SRX176864 | MCF-7 Breast | 287 / 21175 (1.4%) | 12535 / 211750 (5.9%) | −231.3 | −229.0 | 0.23 |
| YAP1 SRX5718140 | 293 Kidney | 727 / 21175 (3.4%) | 19868 / 211750 (9.4%) | −230.9 | −228.6 | 0.37 |
| ESR1 SRX4367193 | MCF-7 Breast | 1407 / 21175 (6.6%) | 29619 / 211750 (14.0%) | −230.9 | −228.6 | 0.48 |
| MECOM SRX23677897 | HNT-34 Blood | 2588 / 21175 (12.2%) | 12479 / 211750 (5.9%) | −230.1 | −227.8 | 2.07 |
| FOXA1 SRX1787653 | MCF-7 Breast | 318 / 21175 (1.5%) | 13072 / 211750 (6.2%) | −230.1 | −227.8 | 0.24 |
| ESR1 SRX371476 | MCF-7 Breast | 301 / 21175 (1.4%) | 12761 / 211750 (6.0%) | −230.1 | −227.8 | 0.24 |
| RUNX1 SRX2014504 | Jurkat Blood | 3038 / 21175 (14.3%) | 15725 / 211750 (7.4%) | −230.0 | −227.7 | 1.93 |
| FOXA1 SRX371480 | MCF-7 Breast | 261 / 21175 (1.2%) | 11996 / 211750 (5.7%) | −229.7 | −227.4 | 0.22 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 371 / 21175 (1.8%) | 14010 / 211750 (6.6%) | −229.6 | −227.2 | 0.26 |
| JUND SRX190357 | SK-N-SH Neural | 523 / 21175 (2.5%) | 16583 / 211750 (7.8%) | −229.4 | −227.1 | 0.32 |
| FOSL1 SRX14181206 | MSK-PCa3 Prostate | 737 / 21175 (3.5%) | 19959 / 211750 (9.4%) | −229.1 | −226.8 | 0.37 |
| KAT6A SRX20971022 | Fibroblasts Others | 296 / 21175 (1.4%) | 80 / 211750 (0.0%) | −229.1 | −226.8 | 37.00 |
| AR SRX1067071 | LHSAR Prostate | 857 / 21175 (4.0%) | 21755 / 211750 (10.3%) | −228.8 | −226.5 | 0.39 |
| ESR1 SRX176860 | MCF-7 Breast | 718 / 21175 (3.4%) | 19640 / 211750 (9.3%) | −228.4 | −226.1 | 0.37 |
| FOSL2 SRX10640864 | SK-MEL-147 Epidermis | 555 / 21175 (2.6%) | 17062 / 211750 (8.1%) | −228.1 | −225.8 | 0.33 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 309 / 21175 (1.5%) | 12843 / 211750 (6.1%) | −228.0 | −225.7 | 0.24 |
| PTEN SRX5416007 | SMMC-7721 Liver | 2262 / 21175 (10.7%) | 10275 / 211750 (4.9%) | −227.8 | −225.5 | 2.20 |
| ESR1 SRX371479 | MCF-7 Breast | 391 / 21175 (1.8%) | 14280 / 211750 (6.7%) | −227.0 | −224.7 | 0.27 |
| TP53 SRX19538281 | Osteoblasts Bone | 437 / 21175 (2.1%) | 387 / 211750 (0.2%) | −226.7 | −224.4 | 11.29 |
| SMARCA4 SRX5075170 | Neural progenitor cells Neural | 1054 / 21175 (5.0%) | 24527 / 211750 (11.6%) | −226.3 | −224.1 | 0.43 |
| ESR1 SRX20282960 | MCF-7 Breast | 493 / 21175 (2.3%) | 15955 / 211750 (7.5%) | −225.3 | −223.0 | 0.31 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 370 / 21175 (1.7%) | 13851 / 211750 (6.5%) | −225.0 | −222.7 | 0.27 |
| SMARCA4 SRX5075169 | Neural progenitor cells Neural | 843 / 21175 (4.0%) | 21392 / 211750 (10.1%) | −224.6 | −222.3 | 0.39 |
| SS18 SRX10640842 | SK-MEL-147 Epidermis | 539 / 21175 (2.5%) | 16671 / 211750 (7.9%) | −224.1 | −221.8 | 0.32 |
| WDR5 SRX5416008 | SMMC-7721 Liver | 2249 / 21175 (10.6%) | 10271 / 211750 (4.9%) | −223.7 | −221.4 | 2.19 |
| AR SRX1067070 | LHSAR Prostate | 1083 / 21175 (5.1%) | 24831 / 211750 (11.7%) | −223.4 | −221.1 | 0.44 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 383 / 21175 (1.8%) | 14022 / 211750 (6.6%) | −223.2 | −221.0 | 0.27 |
| ESR1 SRX371471 | ZR-75-1 Breast | 473 / 21175 (2.2%) | 15550 / 211750 (7.3%) | −223.1 | −220.9 | 0.30 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 552 / 21175 (2.6%) | 16841 / 211750 (8.0%) | −223.0 | −220.7 | 0.33 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 961 / 21175 (4.5%) | 23062 / 211750 (10.9%) | −222.9 | −220.7 | 0.42 |
| JUNB SRX8488074 | SUM 229PE Breast | 563 / 21175 (2.7%) | 17007 / 211750 (8.0%) | −222.6 | −220.3 | 0.33 |
| Epitope tags SRX10549778 | K-562 Blood | 1423 / 21175 (6.7%) | 5015 / 211750 (2.4%) | −222.6 | −220.3 | 2.84 |
| GATA3 SRX5057632 | MCF-7 Breast | 261 / 21175 (1.2%) | 11772 / 211750 (5.6%) | −222.2 | −219.9 | 0.22 |
| FOXA1 SRX1161174 | MCF-7 Breast | 432 / 21175 (2.0%) | 14828 / 211750 (7.0%) | −222.1 | −219.9 | 0.29 |
| FOXA2 SRX6441755 | CFPAC-1 Pancreas | 304 / 21175 (1.4%) | 12550 / 211750 (5.9%) | −221.2 | −219.0 | 0.24 |
| FOXA1 SRX100454 | T-47D Breast | 562 / 21175 (2.7%) | 16938 / 211750 (8.0%) | −221.1 | −218.8 | 0.33 |
| LEO1 SRX1873456 | SEM Blood | 1810 / 21175 (8.5%) | 7416 / 211750 (3.5%) | −221.1 | −218.8 | 2.44 |
| JUNB SRX8488089 | SUM 229PE Breast | 417 / 21175 (2.0%) | 14486 / 211750 (6.8%) | −219.4 | −217.2 | 0.29 |
| ESR1 SRX20282939 | MCF-7 Breast | 511 / 21175 (2.4%) | 15987 / 211750 (7.5%) | −217.3 | −215.1 | 0.32 |
| RAC1 SRX10365541 | MCF-7 Breast | 208 / 21175 (1.0%) | 10587 / 211750 (5.0%) | −216.8 | −214.5 | 0.20 |
| FOXA2 SRX6441754 | CFPAC-1 Pancreas | 297 / 21175 (1.4%) | 12272 / 211750 (5.8%) | −216.4 | −214.2 | 0.24 |
| BRPF1 SRX10606575 | GIST-T1 Digestive tract | 863 / 21175 (4.1%) | 2089 / 211750 (1.0%) | −216.3 | −214.0 | 4.13 |
| FOS SRX070879 | HUVEC Cardiovascular | 446 / 21175 (2.1%) | 14868 / 211750 (7.0%) | −216.1 | −213.9 | 0.30 |
| TET2 SRX1427029 | 293 Kidney | 1638 / 21175 (7.7%) | 6424 / 211750 (3.0%) | −215.7 | −213.4 | 2.55 |
| ARID1A SRX5089376 | MCF-7 Breast | 366 / 21175 (1.7%) | 13476 / 211750 (6.4%) | −215.3 | −213.1 | 0.27 |
| SMARCC1 SRX11379505 | Liposarcoma, Myxoid Adipocyte | 776 / 21175 (3.7%) | 20038 / 211750 (9.5%) | −214.9 | −212.7 | 0.39 |
| SMARCC1 SRX11379506 | Liposarcoma, Myxoid Adipocyte | 759 / 21175 (3.6%) | 19775 / 211750 (9.3%) | −214.7 | −212.5 | 0.38 |
| FOXA1 SRX11222441 | MCF-7 Breast | 319 / 21175 (1.5%) | 12619 / 211750 (6.0%) | −214.7 | −212.5 | 0.25 |
| JUNB SRX10119383 | MCF 10A Breast | 276 / 21175 (1.3%) | 11817 / 211750 (5.6%) | −214.2 | −212.0 | 0.23 |
| JUN SRX6582172 | Fibroblasts Others | 578 / 21175 (2.7%) | 16938 / 211750 (8.0%) | −213.5 | −211.3 | 0.34 |
| FOSL2 SRX5054309 | Neural progenitor cells Neural | 429 / 21175 (2.0%) | 14495 / 211750 (6.8%) | −213.4 | −211.2 | 0.30 |
| SMARCC1 SRX11379511 | Liposarcoma, Myxoid Adipocyte | 587 / 21175 (2.8%) | 17054 / 211750 (8.1%) | −212.8 | −210.6 | 0.34 |
| ESR1 SRX371470 | ZR-75-1 Breast | 411 / 21175 (1.9%) | 14161 / 211750 (6.7%) | −212.5 | −210.3 | 0.29 |
| JUN SRX9350646 | Melanoma cell line Epidermis | 580 / 21175 (2.7%) | 16928 / 211750 (8.0%) | −212.4 | −210.2 | 0.34 |
| ESR1 SRX176861 | MCF-7 Breast | 756 / 21175 (3.6%) | 19633 / 211750 (9.3%) | −212.1 | −209.9 | 0.39 |
| Epitope tags SRX8109066 | Gastric cancer cells Digestive tract | 2339 / 21175 (11.0%) | 11163 / 211750 (5.3%) | −211.4 | −209.2 | 2.10 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 740 / 21175 (3.5%) | 19367 / 211750 (9.1%) | −211.4 | −209.2 | 0.38 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 296 / 21175 (1.4%) | 12101 / 211750 (5.7%) | −211.4 | −209.2 | 0.24 |
| SMARCC1 SRX11379504 | Liposarcoma, Myxoid Adipocyte | 1309 / 21175 (6.2%) | 27485 / 211750 (13.0%) | −211.3 | −209.1 | 0.48 |
| FOXA1 SRX3923514 | MCF-7 Breast | 445 / 21175 (2.1%) | 14696 / 211750 (6.9%) | −211.3 | −209.1 | 0.30 |
| NKX2-1 SRX2164786 | A549 Lung | 741 / 21175 (3.5%) | 19367 / 211750 (9.1%) | −210.9 | −208.7 | 0.38 |
| ESR1 SRX194569 | MCF-7 Breast | 476 / 21175 (2.2%) | 15148 / 211750 (7.2%) | −209.5 | −207.3 | 0.31 |
| MEAF6 SRX10606586 | GIST-T1 Digestive tract | 1549 / 21175 (7.3%) | 5980 / 211750 (2.8%) | −209.2 | −207.0 | 2.59 |
| FOXA1 SRX3931054 | MCF-7 Breast | 408 / 21175 (1.9%) | 13995 / 211750 (6.6%) | −208.9 | −206.7 | 0.29 |
| SS18 SRX10640843 | SK-MEL-147 Epidermis | 698 / 21175 (3.3%) | 18627 / 211750 (8.8%) | −208.5 | −206.3 | 0.37 |
| TP53 SRX19538269 | U2OS Bone | 466 / 21175 (2.2%) | 544 / 211750 (0.3%) | −208.2 | −206.0 | 8.57 |
| FOXA1 SRX11222437 | MCF-7 Breast | 305 / 21175 (1.4%) | 12154 / 211750 (5.7%) | −207.8 | −205.6 | 0.25 |
| PBX3 SRX190343 | SK-N-SH Neural | 957 / 21175 (4.5%) | 22421 / 211750 (10.6%) | −207.6 | −205.4 | 0.43 |
| ESR1 SRX1531791 | MCF-7 Breast | 442 / 21175 (2.1%) | 14523 / 211750 (6.9%) | −207.5 | −205.3 | 0.30 |
| FOXA1 SRX1787652 | MCF-7 Breast | 247 / 21175 (1.2%) | 11068 / 211750 (5.2%) | −207.4 | −205.3 | 0.22 |
| RELA SRX5938177 | FaDu Others | 396 / 21175 (1.9%) | 13733 / 211750 (6.5%) | −207.1 | −205.0 | 0.29 |
| FOXA2 SRX5504126 | CFPAC-1 Pancreas | 256 / 21175 (1.2%) | 11227 / 211750 (5.3%) | −207.0 | −204.8 | 0.23 |
| ZFX SRX7805372 | 293 Kidney | 1924 / 21175 (9.1%) | 8429 / 211750 (4.0%) | −206.9 | −204.8 | 2.28 |
| JUN SRX6582171 | GM07492 Others | 890 / 21175 (4.2%) | 21422 / 211750 (10.1%) | −206.8 | −204.6 | 0.42 |
| EP300 SRX2671813 | Fibroblasts Others | 361 / 21175 (1.7%) | 13119 / 211750 (6.2%) | −206.8 | −204.6 | 0.28 |
| FOXA1 SRX3931055 | MCF-7 Breast | 367 / 21175 (1.7%) | 13215 / 211750 (6.2%) | −206.5 | −204.3 | 0.28 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 343 / 21175 (1.6%) | 12793 / 211750 (6.0%) | −206.4 | −204.3 | 0.27 |
| IRF3 SRX11453861 | Hep G2 Liver | 280 / 21175 (1.3%) | 94 / 211750 (0.0%) | −205.9 | −203.7 | 29.79 |
| ESR1 SRX371467 | MCF-7 Breast | 485 / 21175 (2.3%) | 15169 / 211750 (7.2%) | −205.7 | −203.5 | 0.32 |
| VGLL1 SRX24602130 | BT-20 Breast | 471 / 21175 (2.2%) | 14937 / 211750 (7.1%) | −205.5 | −203.3 | 0.32 |
| KAT7 DRX234808 | 293 Kidney | 979 / 21175 (4.6%) | 2777 / 211750 (1.3%) | −205.0 | −202.8 | 3.53 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 451 / 21175 (2.1%) | 14584 / 211750 (6.9%) | −204.9 | −202.7 | 0.31 |
| FOS SRX3322636 | MCF-7 Breast | 270 / 21175 (1.3%) | 11418 / 211750 (5.4%) | −204.7 | −202.5 | 0.24 |
| TEAD1 SRX3401272 | MCF-7 Breast | 327 / 21175 (1.5%) | 12432 / 211750 (5.9%) | −204.0 | −201.9 | 0.26 |
| ESR1 SRX20282954 | MCF-7 Breast | 507 / 21175 (2.4%) | 15469 / 211750 (7.3%) | −203.8 | −201.7 | 0.33 |
| FOXA1 SRX3931043 | MCF-7 Breast | 455 / 21175 (2.1%) | 14613 / 211750 (6.9%) | −203.7 | −201.5 | 0.31 |
| ESR1 SRX194572 | MCF-7 Breast | 284 / 21175 (1.3%) | 11626 / 211750 (5.5%) | −203.1 | −200.9 | 0.24 |
| JUNB SRX10119384 | MCF 10A Breast | 253 / 21175 (1.2%) | 11051 / 211750 (5.2%) | −203.0 | −200.8 | 0.23 |
| SMARCC1 SRX11379517 | Liposarcoma, Myxoid Adipocyte | 369 / 21175 (1.7%) | 13130 / 211750 (6.2%) | −202.8 | −200.7 | 0.28 |
| ESR1 SRX371468 | MCF-7 Breast | 288 / 21175 (1.4%) | 11683 / 211750 (5.5%) | −202.5 | −200.3 | 0.25 |
| FOS SRX150664 | HUVEC Cardiovascular | 600 / 21175 (2.8%) | 16901 / 211750 (8.0%) | −202.5 | −200.3 | 0.36 |
| TAL1 SRX393518 | Primary endothelial cells Cardiovascular | 648 / 21175 (3.1%) | 17638 / 211750 (8.3%) | −202.3 | −200.2 | 0.37 |
| ESR1 SRX20282972 | MCF-7 Breast | 524 / 21175 (2.5%) | 15679 / 211750 (7.4%) | −202.0 | −199.9 | 0.33 |
| JUN SRX2355072 | HAEC Cardiovascular | 597 / 21175 (2.8%) | 16835 / 211750 (8.0%) | −201.9 | −199.8 | 0.35 |
| KMT2A SRX2323891 | 293 Kidney | 1219 / 21175 (5.8%) | 4139 / 211750 (2.0%) | −200.9 | −198.7 | 2.95 |
| MED1 SRX4937342 | HCT 116 Digestive tract | 1660 / 21175 (7.8%) | 6824 / 211750 (3.2%) | −200.7 | −198.6 | 2.43 |
| MEN1 SRX11712604 | K-562 Blood | 1738 / 21175 (8.2%) | 7329 / 211750 (3.5%) | −200.6 | −198.4 | 2.37 |
| YAP1 SRX10119364 | MCF 10A Breast | 372 / 21175 (1.8%) | 13109 / 211750 (6.2%) | −200.5 | −198.4 | 0.28 |
| TLE3 SRX4815192 | MCF-7 Breast | 407 / 21175 (1.9%) | 13704 / 211750 (6.5%) | −200.5 | −198.4 | 0.30 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 759 / 21175 (3.6%) | 1745 / 211750 (0.8%) | −200.4 | −198.3 | 4.35 |
| STAT1 SRX23678708 | K-562 Blood | 1869 / 21175 (8.8%) | 8201 / 211750 (3.9%) | −200.1 | −198.0 | 2.28 |
| ERG SRX063922 | K-562 Blood | 1916 / 21175 (9.0%) | 8518 / 211750 (4.0%) | −199.9 | −197.8 | 2.25 |
| DOT1L SRX10606581 | GIST-T1 Digestive tract | 2520 / 21175 (11.9%) | 12733 / 211750 (6.0%) | −199.6 | −197.5 | 1.98 |
| FOXA1 SRX11222442 | MCF-7 Breast | 293 / 21175 (1.4%) | 11687 / 211750 (5.5%) | −199.6 | −197.5 | 0.25 |
| TP53 SRX19538270 | U2OS Bone | 449 / 21175 (2.1%) | 530 / 211750 (0.3%) | −199.3 | −197.2 | 8.47 |
| STAT3 SRX150479 | MCF 10A Breast | 423 / 21175 (2.0%) | 13919 / 211750 (6.6%) | −198.9 | −196.8 | 0.30 |
| EP300 SRX2671792 | Cardiac progenitor cells Cardiovascular | 328 / 21175 (1.5%) | 12257 / 211750 (5.8%) | −197.9 | −195.8 | 0.27 |
| FOXA1 SRX028634 | MCF-7 Breast | 208 / 21175 (1.0%) | 10025 / 211750 (4.7%) | −197.5 | −195.4 | 0.21 |
| RAC1 SRX10365543 | MCF-7 Breast | 237 / 21175 (1.1%) | 10575 / 211750 (5.0%) | −197.2 | −195.1 | 0.22 |
| JUND SRX150408 | HeLa Uterus | 390 / 21175 (1.8%) | 13300 / 211750 (6.3%) | −197.0 | −194.9 | 0.29 |
| NANOG SRX5286327 | ES cells Pluripotent stem cell | 319 / 21175 (1.5%) | 12070 / 211750 (5.7%) | −196.9 | −194.8 | 0.26 |
| SMARCA4 SRX8588624 | Pulmonary artery endothelial cells Cardiovascular | 827 / 21175 (3.9%) | 20071 / 211750 (9.5%) | −195.6 | −193.5 | 0.41 |
| SS18 SRX10640841 | SK-MEL-147 Epidermis | 669 / 21175 (3.2%) | 17699 / 211750 (8.4%) | −195.1 | −193.0 | 0.38 |
| STAT3 SRX150630 | MCF 10A Breast | 428 / 21175 (2.0%) | 13860 / 211750 (6.5%) | −194.5 | −192.4 | 0.31 |
| FOXL2 SRX6957431 | KGN Gonad | 1086 / 21175 (5.1%) | 23723 / 211750 (11.2%) | −194.5 | −192.4 | 0.46 |
| FOXA1 SRX1787651 | MCF-7 Breast | 244 / 21175 (1.2%) | 10617 / 211750 (5.0%) | −194.1 | −192.1 | 0.23 |
| AR SRX1067067 | LHSAR Prostate | 806 / 21175 (3.8%) | 19707 / 211750 (9.3%) | −194.0 | −191.9 | 0.41 |
| ARID1A SRX5089379 | MCF-7 Breast | 459 / 21175 (2.2%) | 14352 / 211750 (6.8%) | −193.9 | −191.8 | 0.32 |
| ESR1 SRX2897220 | Breast cancer cells Breast | 1909 / 21175 (9.0%) | 8601 / 211750 (4.1%) | −193.6 | −191.5 | 2.22 |
| ESR1 SRX371477 | MCF-7 Breast | 222 / 21175 (1.0%) | 10173 / 211750 (4.8%) | −193.4 | −191.3 | 0.22 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 504 / 21175 (2.4%) | 15057 / 211750 (7.1%) | −193.2 | −191.2 | 0.33 |
| EP300 SRX150579 | HeLa Uterus | 293 / 21175 (1.4%) | 11485 / 211750 (5.4%) | −193.1 | −191.0 | 0.26 |
| FOXA1 SRX5323843 | MCF-7 Breast | 223 / 21175 (1.1%) | 10173 / 211750 (4.8%) | −192.6 | −190.6 | 0.22 |
| FOXA1 SRX3923518 | MCF-7 Breast | 308 / 21175 (1.5%) | 11724 / 211750 (5.5%) | −192.3 | −190.2 | 0.26 |
| JUND SRX699738 | HCASMC Cardiovascular | 658 / 21175 (3.1%) | 17421 / 211750 (8.2%) | −192.1 | −190.0 | 0.38 |
| ESR1 SRX10365536 | MCF-7 Breast | 246 / 21175 (1.2%) | 10577 / 211750 (5.0%) | −191.7 | −189.7 | 0.23 |
| FOXA1 SRX1447317 | MCF-7 Breast | 296 / 21175 (1.4%) | 11485 / 211750 (5.4%) | −191.5 | −189.4 | 0.26 |
| GATA3 SRX6712581 | MCF-7 Breast | 378 / 21175 (1.8%) | 12906 / 211750 (6.1%) | −191.1 | −189.0 | 0.29 |
| MECOM SRX23677890 | HNT-34 Blood | 2183 / 21175 (10.3%) | 10542 / 211750 (5.0%) | −191.1 | −189.0 | 2.07 |
| ERG SRX063921 | K-562 Blood | 1804 / 21175 (8.5%) | 7956 / 211750 (3.8%) | −190.8 | −188.7 | 2.27 |
| FOXA1 SRX3923517 | MCF-7 Breast | 322 / 21175 (1.5%) | 11922 / 211750 (5.6%) | −190.7 | −188.6 | 0.27 |
| MED1 SRX4937338 | HCT 116 Digestive tract | 1717 / 21175 (8.1%) | 7386 / 211750 (3.5%) | −190.6 | −188.5 | 2.32 |
| RORC SRX5359053 | HCC70 Breast | 1518 / 21175 (7.2%) | 6107 / 211750 (2.9%) | −190.5 | −188.4 | 2.49 |
| TP53 SRX2585782 | MDA-MB-231 Breast | 874 / 21175 (4.1%) | 20542 / 211750 (9.7%) | −190.0 | −187.9 | 0.43 |
| CXXC1 SRX1424886 | SEM Blood | 1755 / 21175 (8.3%) | 7651 / 211750 (3.6%) | −189.7 | −187.6 | 2.29 |
| ESR1 SRX20282973 | MCF-7 Breast | 583 / 21175 (2.8%) | 16170 / 211750 (7.6%) | −189.4 | −187.3 | 0.36 |
| JADE3 DRX234809 | 293 Kidney | 1250 / 21175 (5.9%) | 4483 / 211750 (2.1%) | −189.3 | −187.3 | 2.79 |
| FOXA1 SRX3923516 | MCF-7 Breast | 329 / 21175 (1.6%) | 12002 / 211750 (5.7%) | −189.3 | −187.2 | 0.27 |
| ESR1 SRX2943591 | MCF-7 Breast | 325 / 21175 (1.5%) | 11919 / 211750 (5.6%) | −188.9 | −186.9 | 0.27 |
| FOXA1 SRX3923529 | ZR-75-1 Breast | 434 / 21175 (2.0%) | 13765 / 211750 (6.5%) | −188.7 | −186.6 | 0.32 |
| JUN SRX2355073 | HAEC Cardiovascular | 590 / 21175 (2.8%) | 16251 / 211750 (7.7%) | −188.5 | −186.4 | 0.36 |
| FOSL2 SRX190204 | A549 Lung | 462 / 21175 (2.2%) | 14211 / 211750 (6.7%) | −188.3 | −186.3 | 0.33 |
| GRHL3 SRX2582162 | NHEK Epidermis | 1293 / 21175 (6.1%) | 4762 / 211750 (2.2%) | −188.0 | −185.9 | 2.72 |
| FOXA1 SRX11222438 | MCF-7 Breast | 243 / 21175 (1.1%) | 10392 / 211750 (4.9%) | −187.5 | −185.4 | 0.23 |
| FOXA1 SRX028635 | MCF-7 Breast | 223 / 21175 (1.1%) | 10019 / 211750 (4.7%) | −187.5 | −185.4 | 0.22 |
| MECOM SRX23677891 | HNT-34 Blood | 2163 / 21175 (10.2%) | 10493 / 211750 (5.0%) | −187.2 | −185.2 | 2.06 |
| TEAD4 SRX10640862 | SK-MEL-147 Epidermis | 738 / 21175 (3.5%) | 18437 / 211750 (8.7%) | −187.0 | −184.9 | 0.40 |
| Epitope tags SRX11470449 | Mesenchymal stem cells Others | 725 / 21175 (3.4%) | 18221 / 211750 (8.6%) | −186.3 | −184.3 | 0.40 |
| DNA-RNA hybrid SRX20083260 | SH-SY5Y Neural | 1056 / 21175 (5.0%) | 3412 / 211750 (1.6%) | −186.3 | −184.2 | 3.09 |
| ESR1 SRX371475 | BT-474 Breast | 234 / 21175 (1.1%) | 10189 / 211750 (4.8%) | −186.2 | −184.2 | 0.23 |
| STAT3 SRX150536 | MCF 10A Breast | 540 / 21175 (2.6%) | 15385 / 211750 (7.3%) | −186.1 | −184.1 | 0.35 |
| FOXA2 SRX6441751 | CFPAC-1 Pancreas | 195 / 21175 (0.9%) | 9434 / 211750 (4.5%) | −186.1 | −184.0 | 0.21 |
| ATF1 SRX11470446 | Mesenchymal stem cells Others | 1209 / 21175 (5.7%) | 25067 / 211750 (11.8%) | −186.0 | −184.0 | 0.48 |
| TAZ SRX14181208 | MSK-PCa3 Prostate | 504 / 21175 (2.4%) | 14810 / 211750 (7.0%) | −186.0 | −184.0 | 0.34 |
| EP300 SRX176885 | MCF-7 Breast | 238 / 21175 (1.1%) | 10213 / 211750 (4.8%) | −184.5 | −182.5 | 0.23 |
| Crotonyllysine SRX19488269 | GSC23 Neural | 1469 / 21175 (6.9%) | 5907 / 211750 (2.8%) | −184.2 | −182.2 | 2.49 |
| FOXA1 SRX9419952 | SK-BR-3 Breast | 462 / 21175 (2.2%) | 14066 / 211750 (6.6%) | −184.1 | −182.0 | 0.33 |
| DAXX SRX1021630 | PC-3 Prostate | 481 / 21175 (2.3%) | 14367 / 211750 (6.8%) | −183.9 | −181.8 | 0.33 |
| DNA-RNA hybrid SRX20083259 | SH-SY5Y Neural | 965 / 21175 (4.6%) | 2948 / 211750 (1.4%) | −183.7 | −181.7 | 3.27 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 438 / 21175 (2.1%) | 13659 / 211750 (6.5%) | −183.6 | −181.6 | 0.32 |
| TRIM25 SRX1660872 | Breast cancer cells Breast | 1979 / 21175 (9.3%) | 9299 / 211750 (4.4%) | −183.5 | −181.4 | 2.13 |
| RORC SRX5359052 | HCC70 Breast | 1550 / 21175 (7.3%) | 6437 / 211750 (3.0%) | −183.4 | −181.4 | 2.41 |
| FOS SRX7760064 | CFPAC-1 Pancreas | 377 / 21175 (1.8%) | 12636 / 211750 (6.0%) | −183.3 | −181.3 | 0.30 |
| FOXA1 SRX3931033 | MCF-7 Breast | 294 / 21175 (1.4%) | 11191 / 211750 (5.3%) | −183.2 | −181.2 | 0.26 |
| JUN SRX150358 | HUVEC Cardiovascular | 302 / 21175 (1.4%) | 11330 / 211750 (5.4%) | −183.1 | −181.0 | 0.27 |
| TP53 SRX19538282 | Osteoblasts Bone | 378 / 21175 (1.8%) | 386 / 211750 (0.2%) | −182.2 | −180.2 | 9.79 |
| AR SRX9469988 | LAPC-4 Prostate | 660 / 21175 (3.1%) | 17075 / 211750 (8.1%) | −181.8 | −179.8 | 0.39 |
| FOXA1 SRX1389379 | CFPAC-1 Pancreas | 318 / 21175 (1.5%) | 11564 / 211750 (5.5%) | −181.5 | −179.5 | 0.27 |
| STAT1 SRX23678707 | K-562 Blood | 1714 / 21175 (8.1%) | 7545 / 211750 (3.6%) | −181.5 | −179.5 | 2.27 |
| ESR1 SRX20282940 | MCF-7 Breast | 541 / 21175 (2.6%) | 15233 / 211750 (7.2%) | −181.5 | −179.4 | 0.36 |
| FOXA1 SRX8083099 | CAMA-1 Breast | 459 / 21175 (2.2%) | 13921 / 211750 (6.6%) | −181.2 | −179.2 | 0.33 |
| FOXA2 SRX3230382 | Hep G2 Liver | 670 / 21175 (3.2%) | 17207 / 211750 (8.1%) | −181.2 | −179.2 | 0.39 |
| FOXA1 SRX1787655 | MCF-7 Breast | 231 / 21175 (1.1%) | 9974 / 211750 (4.7%) | −181.1 | −179.0 | 0.23 |
| FOXA1 SRX100506 | Hep G2 Liver | 656 / 21175 (3.1%) | 16987 / 211750 (8.0%) | −181.0 | −179.0 | 0.39 |
| EP300 SRX100540 | SK-N-SH Neural | 711 / 21175 (3.4%) | 17791 / 211750 (8.4%) | −180.5 | −178.5 | 0.40 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 590 / 21175 (2.8%) | 1161 / 211750 (0.5%) | −180.3 | −178.3 | 5.08 |
| ARID1A SRX5089385 | MCF-7 Breast | 354 / 21175 (1.7%) | 12144 / 211750 (5.7%) | −180.2 | −178.2 | 0.29 |
| RBFOX2 SRX4708034 | Hep G2 Liver | 2273 / 21175 (10.7%) | 11452 / 211750 (5.4%) | −180.0 | −178.0 | 1.98 |
| FOS SRX7760063 | CFPAC-1 Pancreas | 291 / 21175 (1.4%) | 11025 / 211750 (5.2%) | −179.5 | −177.5 | 0.26 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 230 / 21175 (1.1%) | 9908 / 211750 (4.7%) | −179.5 | −177.5 | 0.23 |
| FOS SRX3322637 | MCF-7 Breast | 242 / 21175 (1.1%) | 10131 / 211750 (4.8%) | −179.4 | −177.4 | 0.24 |
| MethylCap SRX014767 | NB-4 Blood | 2058 / 21175 (9.7%) | 9945 / 211750 (4.7%) | −179.3 | −177.3 | 2.07 |
| Epitope tags SRX10549777 | K-562 Blood | 2916 / 21175 (13.8%) | 16241 / 211750 (7.7%) | −179.2 | −177.2 | 1.80 |
| FOXA1 SRX3931056 | MCF-7 Breast | 275 / 21175 (1.3%) | 10723 / 211750 (5.1%) | −179.2 | −177.2 | 0.26 |
| AR SRX1067066 | LHSAR Prostate | 1041 / 21175 (4.9%) | 22462 / 211750 (10.6%) | −178.9 | −176.9 | 0.46 |
| JUN SRX7277180 | GM07492 Others | 407 / 21175 (1.9%) | 12980 / 211750 (6.1%) | −178.6 | −176.7 | 0.31 |
| ESR1 SRX10365532 | MCF-7 Breast | 266 / 21175 (1.3%) | 10541 / 211750 (5.0%) | −178.5 | −176.5 | 0.25 |
| CEBPB SRX150632 | HeLa Uterus | 1116 / 21175 (5.3%) | 23479 / 211750 (11.1%) | −178.4 | −176.5 | 0.48 |
| YAP1 SRX10119388 | MDA-MB-231 Breast | 335 / 21175 (1.6%) | 11754 / 211750 (5.6%) | −178.4 | −176.4 | 0.29 |
| ESR1 SRX371474 | BT-474 Breast | 222 / 21175 (1.0%) | 9721 / 211750 (4.6%) | −178.3 | −176.4 | 0.23 |
| ESR1 SRX20282946 | MCF-7 Breast | 291 / 21175 (1.4%) | 10980 / 211750 (5.2%) | −178.3 | −176.3 | 0.27 |
| ESR1 SRX1161185 | ZR-75-1 Breast | 235 / 21175 (1.1%) | 9939 / 211750 (4.7%) | −177.4 | −175.5 | 0.24 |
| FOXA1 SRX1161203 | T-47D Breast | 345 / 21175 (1.6%) | 11892 / 211750 (5.6%) | −177.3 | −175.3 | 0.29 |
| ESR1 SRX10365535 | MCF-7 Breast | 412 / 21175 (1.9%) | 13007 / 211750 (6.1%) | −177.0 | −175.0 | 0.32 |
| SMARCA4 SRX5075175 | Neural progenitor cells Neural | 734 / 21175 (3.5%) | 17988 / 211750 (8.5%) | −176.6 | −174.6 | 0.41 |
| FOXA1 SRX8083098 | CAMA-1 Breast | 401 / 21175 (1.9%) | 12808 / 211750 (6.0%) | −176.4 | −174.4 | 0.31 |
| FOXA1 SRX5124035 | 22Rv1 Prostate | 640 / 21175 (3.0%) | 16572 / 211750 (7.8%) | −176.4 | −174.4 | 0.39 |
| MAML1 SRX8970969 | Squamous cell carcinoma Others | 481 / 21175 (2.3%) | 14103 / 211750 (6.7%) | −176.3 | −174.3 | 0.34 |
| ESR1 SRX20282955 | MCF-7 Breast | 534 / 21175 (2.5%) | 14934 / 211750 (7.1%) | −176.1 | −174.2 | 0.36 |
| FOXA1 SRX15430999 | T-47D Breast | 552 / 21175 (2.6%) | 15211 / 211750 (7.2%) | −176.0 | −174.1 | 0.36 |
| FOXA1 SRX5203303 | MCF-7 Breast | 154 / 21175 (0.7%) | 8317 / 211750 (3.9%) | −175.9 | −173.9 | 0.19 |
| LEO1 SRX15147190 | DLD-1 Digestive tract | 1034 / 21175 (4.9%) | 3433 / 211750 (1.6%) | −175.5 | −173.5 | 3.01 |
| ING2 SRX286201 | RKO Digestive tract | 1668 / 21175 (7.9%) | 7373 / 211750 (3.5%) | −174.9 | −173.0 | 2.26 |
| ZFX SRX7805370 | 293 Kidney | 1361 / 21175 (6.4%) | 5395 / 211750 (2.5%) | −174.7 | −172.8 | 2.52 |
| NANOG SRX20532161 | hESC HUES8 Pluripotent stem cell | 1299 / 21175 (6.1%) | 25790 / 211750 (12.2%) | −174.6 | −172.7 | 0.50 |
| NR1H3 SRX1538760 | HT-29 Digestive tract | 466 / 21175 (2.2%) | 13800 / 211750 (6.5%) | −174.5 | −172.5 | 0.34 |
| SMARCA4 SRX5982340 | A549 Lung | 186 / 21175 (0.9%) | 8914 / 211750 (4.2%) | −174.4 | −172.5 | 0.21 |
| NANOG SRX3288567 | hESC H9 Pluripotent stem cell | 168 / 21175 (0.8%) | 8557 / 211750 (4.0%) | −174.4 | −172.5 | 0.20 |
| MED1 SRX4937336 | HCT 116 Digestive tract | 1886 / 21175 (8.9%) | 8862 / 211750 (4.2%) | −174.4 | −172.4 | 2.13 |
| TEAD4 SRX10640861 | SK-MEL-147 Epidermis | 535 / 21175 (2.5%) | 14891 / 211750 (7.0%) | −174.4 | −172.4 | 0.36 |
| FOXA2 SRX2368889 | Ker-CT Epidermis | 407 / 21175 (1.9%) | 12834 / 211750 (6.1%) | −174.3 | −172.4 | 0.32 |
| INTS3 SRX3640569 | HeLa Uterus | 1505 / 21175 (7.1%) | 6320 / 211750 (3.0%) | −174.2 | −172.2 | 2.38 |
| YAP1 SRX1038945 | IMR-90 Lung | 376 / 21175 (1.8%) | 12311 / 211750 (5.8%) | −174.1 | −172.1 | 0.31 |
| FOSL2 SRX5054308 | Neural progenitor cells Neural | 355 / 21175 (1.7%) | 11952 / 211750 (5.6%) | −174.0 | −172.0 | 0.30 |
| FOXA1 SRX190181 | A549 Lung | 354 / 21175 (1.7%) | 11934 / 211750 (5.6%) | −173.9 | −171.9 | 0.30 |
| TLE3 SRX4815194 | SUM 149PT Breast | 379 / 21175 (1.8%) | 12353 / 211750 (5.8%) | −173.9 | −171.9 | 0.31 |
| Epitope tags SRX11470445 | Mesenchymal stem cells Others | 642 / 21175 (3.0%) | 16509 / 211750 (7.8%) | −173.9 | −171.9 | 0.39 |
| STAT3 SRX2020842 | HCC70 Breast | 895 / 21175 (4.2%) | 20203 / 211750 (9.5%) | −173.7 | −171.8 | 0.44 |
| JUNB SRX10119385 | MCF 10A Breast | 218 / 21175 (1.0%) | 9507 / 211750 (4.5%) | −173.7 | −171.8 | 0.23 |
| EP300 ERX626821 | U-937 Blood | 1456 / 21175 (6.9%) | 6015 / 211750 (2.8%) | −173.7 | −171.7 | 2.42 |
| TEAD1 SRX14688734 | HUVEC Cardiovascular | 429 / 21175 (2.0%) | 13170 / 211750 (6.2%) | −173.6 | −171.6 | 0.33 |
| DNA-RNA hybrid SRX20083265 | SH-SY5Y Neural | 898 / 21175 (4.2%) | 2711 / 211750 (1.3%) | −173.4 | −171.5 | 3.31 |
| FOXA1 SRX3923519 | MCF-7 Breast | 301 / 21175 (1.4%) | 11000 / 211750 (5.2%) | −173.3 | −171.3 | 0.27 |
| EP300 SRX027482 | hESC H9 Pluripotent stem cell | 433 / 21175 (2.0%) | 13209 / 211750 (6.2%) | −172.8 | −170.9 | 0.33 |
| FOXA2 SRX100448 | Hep G2 Liver | 563 / 21175 (2.7%) | 15265 / 211750 (7.2%) | −172.8 | −170.9 | 0.37 |
| EP300 ERX626811 | U-937 Blood | 1454 / 21175 (6.9%) | 6019 / 211750 (2.8%) | −172.6 | −170.6 | 2.42 |
| FOXA1 SRX3923515 | MCF-7 Breast | 273 / 21175 (1.3%) | 10481 / 211750 (4.9%) | −172.5 | −170.6 | 0.26 |
| ESR1 SRX4451213 | MCF-7 Breast | 511 / 21175 (2.4%) | 14437 / 211750 (6.8%) | −172.3 | −170.3 | 0.35 |
| FOSL1 SRX190212 | HCT 116 Digestive tract | 573 / 21175 (2.7%) | 15397 / 211750 (7.3%) | −172.2 | −170.3 | 0.37 |
| ARID1A SRX5089391 | MCF-7 Breast | 274 / 21175 (1.3%) | 10485 / 211750 (5.0%) | −172.0 | −170.1 | 0.26 |
| ESR1 SRX2943589 | MCF-7 Breast | 250 / 21175 (1.2%) | 10041 / 211750 (4.7%) | −171.8 | −169.8 | 0.25 |
| ESR1 SRX4367192 | MCF-7 Breast | 1022 / 21175 (4.8%) | 21900 / 211750 (10.3%) | −171.7 | −169.7 | 0.47 |
| Epitope tags SRX11470532 | Mesenchymal stem cells Others | 673 / 21175 (3.2%) | 16889 / 211750 (8.0%) | −171.5 | −169.6 | 0.40 |
| FOSL1 SRX2585779 | MDA-MB-231 Breast | 237 / 21175 (1.1%) | 9787 / 211750 (4.6%) | −171.3 | −169.4 | 0.24 |
| CARM1 SRX10562203 | MDA-MB-231 Breast | 268 / 21175 (1.3%) | 144 / 211750 (0.1%) | −171.2 | −169.3 | 18.61 |
| ZNF711 SRX7805363 | 293 Kidney | 1810 / 21175 (8.5%) | 8415 / 211750 (4.0%) | −171.1 | −169.1 | 2.15 |
| JUNB SRX4677294 | CFPAC-1 Pancreas | 309 / 21175 (1.5%) | 11063 / 211750 (5.2%) | −170.9 | −168.9 | 0.28 |
| ARID1A SRX5679787 | 12Z Others | 188 / 21175 (0.9%) | 8847 / 211750 (4.2%) | −170.9 | −168.9 | 0.21 |
| FOXA1 SRX3923532 | ZR-75-1 Breast | 331 / 21175 (1.6%) | 11442 / 211750 (5.4%) | −170.9 | −168.9 | 0.29 |
| KDM1A SRX10637290 | MDA-MB-231 Breast | 647 / 21175 (3.1%) | 16475 / 211750 (7.8%) | −170.8 | −168.9 | 0.39 |
| ESR1 SRX330067 | MCF-7 Breast | 463 / 21175 (2.2%) | 13620 / 211750 (6.4%) | −170.7 | −168.8 | 0.34 |
| NKX2-1 SRX366169 | NCI-H441 Lung | 605 / 21175 (2.9%) | 15831 / 211750 (7.5%) | −170.7 | −168.8 | 0.38 |
| ESR1 SRX10365533 | MCF-7 Breast | 239 / 21175 (1.1%) | 9798 / 211750 (4.6%) | −170.5 | −168.5 | 0.24 |
| CEBPB SRX11379528 | Liposarcoma, Myxoid Adipocyte | 1149 / 21175 (5.4%) | 23575 / 211750 (11.1%) | −170.1 | −168.2 | 0.49 |
| RBFOX2 SRX4708082 | K-562 Blood | 2776 / 21175 (13.1%) | 15453 / 211750 (7.3%) | −170.1 | −168.1 | 1.80 |
| SMARCA4 SRX027488 | hESC H9 Pluripotent stem cell | 127 / 21175 (0.6%) | 7588 / 211750 (3.6%) | −170.0 | −168.0 | 0.17 |
| SMARCA4 SRX8588623 | Pulmonary artery endothelial cells Cardiovascular | 720 / 21175 (3.4%) | 17525 / 211750 (8.3%) | −169.9 | −168.0 | 0.41 |
| ARID1A SRX5089382 | MCF-7 Breast | 354 / 21175 (1.7%) | 11793 / 211750 (5.6%) | −169.7 | −167.7 | 0.30 |
| FOXA1 SRX1961157 | T-47D Breast | 550 / 21175 (2.6%) | 14950 / 211750 (7.1%) | −169.6 | −167.7 | 0.37 |
| FOXA1 SRX1787654 | MCF-7 Breast | 173 / 21175 (0.8%) | 8513 / 211750 (4.0%) | −169.5 | −167.6 | 0.20 |
| ESR1 SRX2881000 | MCF-7 Breast | 453 / 21175 (2.1%) | 13417 / 211750 (6.3%) | −169.5 | −167.5 | 0.34 |
| EP300 SRX2194265 | SUM 159PT Breast | 802 / 21175 (3.8%) | 18697 / 211750 (8.8%) | −169.4 | −167.4 | 0.43 |
| MED1 SRX4937340 | HCT 116 Digestive tract | 1885 / 21175 (8.9%) | 8971 / 211750 (4.2%) | −169.3 | −167.4 | 2.10 |
| FOXA1 SRX3931032 | MCF-7 Breast | 288 / 21175 (1.4%) | 10640 / 211750 (5.0%) | −169.1 | −167.2 | 0.27 |
| FOXA1 SRX3923528 | ZR-75-1 Breast | 337 / 21175 (1.6%) | 11482 / 211750 (5.4%) | −168.9 | −167.0 | 0.29 |
| FOXA1 SRX5323845 | MCF-7 Breast | 176 / 21175 (0.8%) | 8554 / 211750 (4.0%) | −168.9 | −167.0 | 0.21 |
| RELA SRX7054617 | HAEC Cardiovascular | 612 / 21175 (2.9%) | 15865 / 211750 (7.5%) | −168.7 | −166.8 | 0.39 |
| NANOG SRX20532160 | hESC HUES8 Pluripotent stem cell | 1478 / 21175 (7.0%) | 27879 / 211750 (13.2%) | −168.5 | −166.6 | 0.53 |
| KMT2A SRX2281249 | SEM Blood | 2275 / 21175 (10.7%) | 11765 / 211750 (5.6%) | −168.4 | −166.5 | 1.93 |
| WWTR1 SRX10119367 | MCF 10A Breast | 604 / 21175 (2.9%) | 15724 / 211750 (7.4%) | −168.2 | −166.3 | 0.38 |
| ZEB1 SRX13298925 | MCF-7 Breast | 309 / 21175 (1.5%) | 10975 / 211750 (5.2%) | −168.2 | −166.3 | 0.28 |
| Epitope tags SRX2255894 | 293 Kidney | 1592 / 21175 (7.5%) | 7008 / 211750 (3.3%) | −168.1 | −166.2 | 2.27 |
| KAT7 DRX300414 | 293 Kidney | 735 / 21175 (3.5%) | 1930 / 211750 (0.9%) | −168.1 | −166.2 | 3.81 |
| FOXA2 SRX2368888 | Ker-CT Epidermis | 492 / 21175 (2.3%) | 13988 / 211750 (6.6%) | −168.0 | −166.1 | 0.35 |
| FOXA1 SRX219284 | LNCAP Prostate | 692 / 21175 (3.3%) | 17037 / 211750 (8.0%) | −168.0 | −166.1 | 0.41 |
| ESR1 SRX20282971 | MCF-7 Breast | 513 / 21175 (2.4%) | 14313 / 211750 (6.8%) | −167.9 | −166.0 | 0.36 |
| EP300 SRX1012648 | MCF-7 Breast | 238 / 21175 (1.1%) | 9690 / 211750 (4.6%) | −167.6 | −165.7 | 0.25 |
| FOXA1 SRX5323829 | T-47D Breast | 280 / 21175 (1.3%) | 10447 / 211750 (4.9%) | −167.5 | −165.6 | 0.27 |
| FOXA1 SRX5323830 | T-47D Breast | 298 / 21175 (1.4%) | 10762 / 211750 (5.1%) | −167.5 | −165.6 | 0.28 |
| FOXA1 SRX6860635 | T-47D Breast | 385 / 21175 (1.8%) | 12239 / 211750 (5.8%) | −167.5 | −165.6 | 0.31 |
| GATA3 SRX5457550 | MCF-7 Breast | 578 / 21175 (2.7%) | 15298 / 211750 (7.2%) | −167.3 | −165.4 | 0.38 |
| FOXA1 SRX1447316 | MCF-7 Breast | 210 / 21175 (1.0%) | 9157 / 211750 (4.3%) | −167.2 | −165.3 | 0.23 |
| SMAD3 SRX366168 | NCI-H441 Lung | 445 / 21175 (2.1%) | 13204 / 211750 (6.2%) | −167.1 | −165.2 | 0.34 |
| ZNF711 SRX7805362 | 293 Kidney | 1716 / 21175 (8.1%) | 7861 / 211750 (3.7%) | −167.1 | −165.2 | 2.18 |
| ARID1A SRX5089388 | MCF-7 Breast | 254 / 21175 (1.2%) | 9968 / 211750 (4.7%) | −167.1 | −165.2 | 0.25 |
| NR2F2 SRX190293 | MCF-7 Breast | 546 / 21175 (2.6%) | 14796 / 211750 (7.0%) | −167.1 | −165.2 | 0.37 |
| TEAD1 SRX1011298 | HuCCT1 Liver | 208 / 21175 (1.0%) | 9118 / 211750 (4.3%) | −167.0 | −165.2 | 0.23 |
| ARID1A SRX5679788 | 12Z Others | 212 / 21175 (1.0%) | 9191 / 211750 (4.3%) | −167.0 | −165.1 | 0.23 |
| JUN SRX6582163 | BJ-5ta Epidermis | 653 / 21175 (3.1%) | 16391 / 211750 (7.7%) | −166.2 | −164.4 | 0.40 |
| KAT6A DRX366109 | 293 Kidney | 2415 / 21175 (11.4%) | 12854 / 211750 (6.1%) | −166.2 | −164.3 | 1.88 |
| FOXA1 SRX5203307 | MCF-7 Breast | 140 / 21175 (0.7%) | 7749 / 211750 (3.7%) | −166.2 | −164.3 | 0.18 |
| MethylCap SRX014766 | NB-4 Blood | 1841 / 21175 (8.7%) | 8737 / 211750 (4.1%) | −166.2 | −164.3 | 2.11 |
| RELA SRX7054663 | HAEC Cardiovascular | 438 / 21175 (2.1%) | 13053 / 211750 (6.2%) | −166.0 | −164.1 | 0.34 |
| TET2 SRX2014505 | Jurkat Blood | 3096 / 21175 (14.6%) | 18051 / 211750 (8.5%) | −165.9 | −164.0 | 1.72 |
| AR SRX10820653 | LNCAP Prostate | 312 / 21175 (1.5%) | 263 / 211750 (0.1%) | −165.8 | −163.9 | 11.86 |
| FOXA1 SRX13814018 | 5637 Others | 319 / 21175 (1.5%) | 11066 / 211750 (5.2%) | −165.6 | −163.7 | 0.29 |
| RNF2 SRX18954719 | SCC-25 Others | 694 / 21175 (3.3%) | 16970 / 211750 (8.0%) | −165.5 | −163.6 | 0.41 |
| RELA SRX7054657 | HAEC Cardiovascular | 583 / 21175 (2.8%) | 15303 / 211750 (7.2%) | −165.4 | −163.5 | 0.38 |
| HOXC5 SRX2731653 | PC-3 Prostate | 406 / 21175 (1.9%) | 12511 / 211750 (5.9%) | −165.3 | −163.4 | 0.32 |
| ESR1 SRX2881002 | MCF-7 Breast | 497 / 21175 (2.3%) | 13963 / 211750 (6.6%) | −165.1 | −163.2 | 0.36 |
| NANOG SRX10445309 | Neural crest cells Neural | 282 / 21175 (1.3%) | 10401 / 211750 (4.9%) | −164.9 | −163.1 | 0.27 |
| KAT6A DRX366108 | 293 Kidney | 2013 / 21175 (9.5%) | 9974 / 211750 (4.7%) | −164.9 | −163.1 | 2.02 |
| FOXA1 SRX1961158 | T-47D Breast | 511 / 21175 (2.4%) | 14168 / 211750 (6.7%) | −164.7 | −162.9 | 0.36 |
| FOXA1 SRX3923530 | ZR-75-1 Breast | 335 / 21175 (1.6%) | 11304 / 211750 (5.3%) | −164.6 | −162.8 | 0.30 |
| FOXA1 SRX5323846 | MCF-7 Breast | 187 / 21175 (0.9%) | 8642 / 211750 (4.1%) | −164.6 | −162.7 | 0.22 |
| AFF1 SRX2281250 | SEM Blood | 1131 / 21175 (5.3%) | 4155 / 211750 (2.0%) | −164.6 | −162.7 | 2.72 |
| ESR1 SRX3110725 | MCF-7 Breast | 468 / 21175 (2.2%) | 13483 / 211750 (6.4%) | −164.5 | −162.7 | 0.35 |
| VGLL1 SRX18013277 | FULVR Breast | 219 / 21175 (1.0%) | 9237 / 211750 (4.4%) | −164.2 | −162.3 | 0.24 |
| ESR1 SRX20282938 | MCF-7 Breast | 420 / 21175 (2.0%) | 12699 / 211750 (6.0%) | −164.1 | −162.3 | 0.33 |
| FOXA1 SRX6878603 | LNCAP Prostate | 581 / 21175 (2.7%) | 15226 / 211750 (7.2%) | −164.1 | −162.2 | 0.38 |
| ESR1 SRX330069 | MCF-7 Breast | 321 / 21175 (1.5%) | 11042 / 211750 (5.2%) | −163.9 | −162.0 | 0.29 |
| FOXA1 SRX1161205 | T-47D Breast | 270 / 21175 (1.3%) | 10149 / 211750 (4.8%) | −163.7 | −161.8 | 0.27 |
| NANOG SRX5286326 | hESC WIBR2 Pluripotent stem cell | 436 / 21175 (2.1%) | 12942 / 211750 (6.1%) | −163.7 | −161.8 | 0.34 |
| TAL1 SRX393516 | Primary endothelial cells Cardiovascular | 626 / 21175 (3.0%) | 15885 / 211750 (7.5%) | −163.5 | −161.7 | 0.39 |
| DNA-RNA hybrid SRX21658480 | U2OS Bone | 611 / 21175 (2.9%) | 1386 / 211750 (0.7%) | −163.3 | −161.4 | 4.41 |
| NR3C1 SRX8520809 | SUM 159PT Breast | 462 / 21175 (2.2%) | 13341 / 211750 (6.3%) | −163.2 | −161.4 | 0.35 |
| FOXA2 SRX11650948 | hESC derived pancreatic cells Pluripotent stem cell | 447 / 21175 (2.1%) | 13098 / 211750 (6.2%) | −163.0 | −161.2 | 0.34 |
| FOXA1 SRX3923531 | ZR-75-1 Breast | 292 / 21175 (1.4%) | 10506 / 211750 (5.0%) | −162.7 | −160.9 | 0.28 |
| FOXL2 SRX6957477 | KGN Gonad | 542 / 21175 (2.6%) | 14571 / 211750 (6.9%) | −162.6 | −160.8 | 0.37 |
| NANOG SRX017277 | hESC H1 Pluripotent stem cell | 199 / 21175 (0.9%) | 8811 / 211750 (4.2%) | −162.6 | −160.7 | 0.23 |
| ESR1 SRX20282953 | MCF-7 Breast | 433 / 21175 (2.0%) | 12853 / 211750 (6.1%) | −162.5 | −160.6 | 0.34 |
| GATA3 SRX100559 | T-47D Breast | 580 / 21175 (2.7%) | 15149 / 211750 (7.2%) | −162.4 | −160.6 | 0.38 |
| PRMT1 SRX3642947 | Keratinocytes Epidermis | 297 / 21175 (1.4%) | 10578 / 211750 (5.0%) | −162.4 | −160.5 | 0.28 |
| FOXA1 SRX5203294 | MCF-7 Breast | 141 / 21175 (0.7%) | 7656 / 211750 (3.6%) | −162.1 | −160.3 | 0.18 |
| NABP2 SRX9523535 | HT-1080 Bone | 1588 / 21175 (7.5%) | 7118 / 211750 (3.4%) | −161.5 | −159.6 | 2.23 |
| SMARCA2 SRX5982361 | A549 Lung | 158 / 21175 (0.7%) | 7978 / 211750 (3.8%) | −161.4 | −159.6 | 0.20 |
| GATA1 SRX4172744 | HCT 116 Digestive tract | 1768 / 21175 (8.3%) | 8344 / 211750 (3.9%) | −161.4 | −159.5 | 2.12 |
| CDK9 SRX10131663 | Bronchial tracheal epithelial cells Lung | 1245 / 21175 (5.9%) | 4904 / 211750 (2.3%) | −161.3 | −159.4 | 2.54 |
| RELA SRX7055007 | HAEC Cardiovascular | 939 / 21175 (4.4%) | 20305 / 211750 (9.6%) | −161.1 | −159.2 | 0.46 |
| FOSL1 SRX17608312 | T24 Others | 198 / 21175 (0.9%) | 8738 / 211750 (4.1%) | −160.9 | −159.0 | 0.23 |
| FOXA1 SRX6441748 | CFPAC-1 Pancreas | 173 / 21175 (0.8%) | 8248 / 211750 (3.9%) | −160.5 | −158.7 | 0.21 |
| ESR1 SRX1012632 | MCF-7 Breast | 260 / 21175 (1.2%) | 9867 / 211750 (4.7%) | −160.5 | −158.6 | 0.26 |
| CTNNB1 SRX833403 | hESC H1 Pluripotent stem cell | 147 / 21175 (0.7%) | 7730 / 211750 (3.7%) | −160.4 | −158.6 | 0.19 |
| FOXA1 SRX15430987 | MDA-MB-453 Breast | 767 / 21175 (3.6%) | 17834 / 211750 (8.4%) | −160.4 | −158.5 | 0.43 |
| FOXA1 SRX3931031 | MCF-7 Breast | 243 / 21175 (1.1%) | 9539 / 211750 (4.5%) | −159.7 | −157.9 | 0.25 |
| ATF1 SRX11470450 | Mesenchymal stem cells Others | 1006 / 21175 (4.8%) | 21164 / 211750 (10.0%) | −159.4 | −157.6 | 0.48 |
| YAP1 SRX10119387 | MDA-MB-231 Breast | 390 / 21175 (1.8%) | 12047 / 211750 (5.7%) | −159.4 | −157.6 | 0.32 |
| Epitope tags SRX15939724 | RD Muscle | 464 / 21175 (2.2%) | 13237 / 211750 (6.3%) | −159.3 | −157.5 | 0.35 |
| SP1 SRX190358 | HCT 116 Digestive tract | 798 / 21175 (3.8%) | 18229 / 211750 (8.6%) | −159.1 | −157.2 | 0.44 |
| ESR1 SRX8537722 | MCF-7 Breast | 495 / 21175 (2.3%) | 13713 / 211750 (6.5%) | −159.1 | −157.2 | 0.36 |
| ESR1 SRX330070 | MCF-7 Breast | 277 / 21175 (1.3%) | 10120 / 211750 (4.8%) | −159.0 | −157.2 | 0.27 |
| SMARCA4 SRX5982364 | A549 Lung | 158 / 21175 (0.7%) | 7901 / 211750 (3.7%) | −158.8 | −157.0 | 0.20 |
| EP300 SRX10976215 | A549 Lung | 488 / 21175 (2.3%) | 13596 / 211750 (6.4%) | −158.8 | −156.9 | 0.36 |
| FOXA2 SRX11650944 | hESC derived pancreatic cells Pluripotent stem cell | 458 / 21175 (2.2%) | 13117 / 211750 (6.2%) | −158.7 | −156.9 | 0.35 |
| JUN SRX6582165 | BJ-5ta Epidermis | 999 / 21175 (4.7%) | 21028 / 211750 (9.9%) | −158.6 | −156.7 | 0.48 |
| GRHL3 SRX2582161 | NHEK Epidermis | 1047 / 21175 (4.9%) | 3748 / 211750 (1.8%) | −158.6 | −156.7 | 2.79 |
| EP300 SRX1012643 | MCF-7 Breast | 187 / 21175 (0.9%) | 8461 / 211750 (4.0%) | −158.5 | −156.7 | 0.22 |
| JUN SRX6582164 | BJ-5ta Epidermis | 676 / 21175 (3.2%) | 16426 / 211750 (7.8%) | −158.3 | −156.5 | 0.41 |
| ATF3 SRX2207918 | CS1AN Epidermis | 2643 / 21175 (12.5%) | 14805 / 211750 (7.0%) | −158.1 | −156.3 | 1.79 |
| ESR1 SRX2897217 | Breast cancer cells Breast | 1124 / 21175 (5.3%) | 4213 / 211750 (2.0%) | −158.1 | −156.3 | 2.67 |
| FOXA1 SRX5124036 | 22Rv1 Prostate | 556 / 21175 (2.6%) | 14616 / 211750 (6.9%) | −158.0 | −156.1 | 0.38 |
| PGR SRX1012655 | MCF-7 Breast | 343 / 21175 (1.6%) | 11216 / 211750 (5.3%) | −157.8 | −156.0 | 0.31 |
| SMARCA4 SRX5982341 | A549 Lung | 154 / 21175 (0.7%) | 7780 / 211750 (3.7%) | −157.4 | −155.6 | 0.20 |
| Epitope tags SRX10715360 | HCB1 Blood | 1302 / 21175 (6.1%) | 5344 / 211750 (2.5%) | −156.6 | −154.8 | 2.44 |
| NR3C1 SRX19024866 | MCF-7 Breast | 186 / 21175 (0.9%) | 8379 / 211750 (4.0%) | −156.5 | −154.7 | 0.22 |
| FOXA1 SRX190282 | A549 Lung | 372 / 21175 (1.8%) | 11651 / 211750 (5.5%) | −156.5 | −154.6 | 0.32 |
| KDM4C SRX424010 | KYSE-150 Digestive tract | 1418 / 21175 (6.7%) | 6095 / 211750 (2.9%) | −156.4 | −154.6 | 2.33 |
| FOXA1 SRX9604647 | LNCAP Prostate | 804 / 21175 (3.8%) | 18207 / 211750 (8.6%) | −156.3 | −154.5 | 0.44 |
Showing first 500 of 18578 rows.